Dawn Parsell Otto, EVP, Clinical Development at Tricida, Inc. (TCDA), sold 1,250 shares at $30.31 ($38K) on 2020-05-05, disclosed to the SEC on 2020-05-07.
Scheduled sale ($38k) by EVP, Clinical Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.05 | 798 | $24K | 63.6% |
| 2 | $30.31 | 452 | $14K | 36.4% |
| Total | $30.14 avg | 1,250 | $38K | 100% |
| Filing → |
| TCDA | SELL | 2020-03-04 | $214K | — | Filing → |
| TCDA | SELL | 2020-02-05 | $242K | — | Filing → |
| TCDA | SELL | 2020-01-06 | $227K | — | Filing → |